| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +33.33% | +1.08% | +0.95% | +0.14% | +2.47% | — |
| 14d | 3 | +0.00% | +22.50% | +1.03% | +21.47% | +23.97% | — |
| 30d | 3 | +0.00% | +19.62% | +1.34% | +18.28% | +14.95% | — |
| 60d | 3 | +0.00% | +23.03% | +4.66% | +19.19% | +19.19% | — |
| 90d | 3(1 pending) | +0.00% | +44.32% | +2.04% | +14.42% | +14.42% | — |
| 180d | 3(2 pending) | +0.00% | +100.52% | — | — | — | — |
| 1y | 3(3 pending) | — | — | — | — | — | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 21,661 | — | — | 0 | Jun 11, 2026 | Jun 11, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 100,000 | — | — | 0 | Jun 11, 2026 | Jun 11, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 55,000 | — | — | 0 | Jun 11, 2026 | Jun 11, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 93,750 | — | — | 0 | Jun 11, 2026 | Jun 11, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 1,489 | $26.78 | $39.9K | 21,661 | May 22, 2026 | May 26, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 5,000 | — | — | 23,150 | May 21, 2026 | May 26, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 5,000 | — | — | 55,000 | May 21, 2026 | May 26, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 1,862 | $20.22 | $37.6K | 18,150 | Apr 17, 2026 | Apr 20, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 6,250 | — | — | 20,012 | Apr 16, 2026 | Apr 20, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 6,250 | — | — | 93,750 | Apr 16, 2026 | Apr 20, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 1,767 | $15.57 | $27.5K | 13,762 | Feb 23, 2026 | Feb 24, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 5,000 | — | — | 60,000 | Feb 21, 2026 | Feb 24, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 5,000 | — | — | 15,529 | Feb 21, 2026 | Feb 24, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 16, 2026 | Jan 21, 2026 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 4,471 | $13.45 | $60.1K | 10,529 | Nov 24, 2025 | Nov 26, 2025 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 15,000 | — | — | 15,000 | Nov 21, 2025 | Nov 26, 2025 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 15,000 | — | — | 65,000 | Nov 21, 2025 | Nov 26, 2025 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Feb 21, 2025 | Feb 25, 2025 ↗ | View → |
| KALV KALVISTA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Sep 9, 2024 | Sep 11, 2024 ↗ | View → |
| ELTX ELICIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 43,225 | — | — | 43,225 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| ELTX ELICIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,484 | — | — | 75,484 | Jun 1, 2023 | Jun 5, 2023 ↗ | View → |